Skip to main content

Hip Disorders Program News

Our team of orthopedists, surgeons, radiologists, advanced practice nurses and others consider all possible treatment options for children, adolescents and young adults with hip disorders.

Appointments and referrals

Q&A with Joshua Eisenberg, MD

Aug 9, 2022

Get to know Dr. Joshua Eisenberg, our newest attending physician in the Division of Gastroenterology, Hepatology and Nutrition.

FDA Approves Drug for Rare Cancer

Jul 25, 2022

CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.

Jump back to top